Dem İlac

Istanbul, Turkey Founded: 1970 • Age: 56 yrs
Finished pharmaceutical products are manufactured for hematology, oncology, and surgery.

About Dem İlac

Dem İlac is a Healthcare company based in Istanbul (Turkey) founded in 1970. Finished pharmaceutical products are manufactured for hematology, oncology, and surgery. Its chief executive, as recorded, is Kemal Cebecioglu. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.

Company details

Dem İlaç was established in 1970 in Istanbul, Turkey, within the pharmaceuticals sector. Finished products are manufactured and sold, focusing on hematology, oncology, and surgery areas. Therapeutic categories addressed include anti-infectives, anti-coagulants, myeloproliferative diseases, hormone regulators, proton pump inhibitors, hemophilia A, and related fields. License agreements are maintained with global pharmaceutical companies to support operations.

  • Headquarters Istanbul, Turkey
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website demilac.com.tr
  • Social LinkedIn

People of Dem İlac

1 people are tracked at Dem İlac (1 in leadership).

NameRoleGroup
Kemal Cebecioglu
CEOLeadership
Premium access

Complete people profiles for Dem İlac

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Web traffic of Dem İlac

The website of Dem İlac (demilac.com.tr) receives about 1.9K visits a month and ranks #6,310,367 among all websites worldwide, #6,529 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    1.9K

    ▼ 30.9% vs previous month

  • Unique visitors
    1.2K

    per month

  • Global rank
    #6,310,367

    among all websites

  • Category rank
    #6,529

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Dem İlac. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
frik.com.tr
frik.com.tr
100%
–
santafarma.com.tr
100%
#332,566View details
aroma-polifarma.com
aroma-polifarma.com
100%
–
drogsan.com.tr
drogsan.com.tr
100%
#1,552,222–
wyeth.com.tr
wyeth.com.tr
100%
–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 15 similar websites and full traffic analytics for Dem İlac

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 15 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Dem İlac

Dem İlac was founded in 1970.

Dem İlac is headquartered in Istanbul, Turkey.

Kemal Cebecioglu is the CEO of Dem İlac, as recorded in our data.

Dem İlaç was established in 1970 in Istanbul, Turkey, within the pharmaceuticals sector. Finished products are manufactured and sold, focusing on hematology, oncology, and surgery areas. Therapeutic categories addressed include anti-infectives, anti-coagulants, myeloproliferative diseases, hormone regulators, proton pump inhibitors, hemophilia A, and related fields. License agreements are maintained with global pharmaceutical companies to support operations.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available